Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 5
2006 1
2007 4
2008 3
2009 5
2010 9
2011 5
2012 11
2013 10
2014 8
2015 16
2016 14
2017 24
2018 31
2019 29
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

162 results
Results by year
Filters applied: . Clear all
Page 1
The wide utility of rabbits as models of human diseases.
Esteves PJ, Abrantes J, Baldauf HM, BenMohamed L, Chen Y, Christensen N, González-Gallego J, Giacani L, Hu J, Kaplan G, Keppler OT, Knight KL, Kong XP, Lanning DK, Le Pendu J, de Matos AL, Liu J, Liu S, Lopes AM, Lu S, Lukehart S, Manabe YC, Neves F, McFadden G, Pan R, Peng X, de Sousa-Pereira P, Pinheiro A, Rahman M, Ruvoën-Clouet N, Subbian S, Tuñón MJ, van der Loo W, Vaine M, Via LE, Wang S, Mage R. Esteves PJ, et al. Exp Mol Med. 2018 May 22;50(5):1-10. doi: 10.1038/s12276-018-0094-1. Exp Mol Med. 2018. PMID: 29789565 Free PMC article. Review.
Oncolytic viruses: what to expect from its use in cancer treatment.
Terrível M, Gromicho C, Matos AM. Terrível M, et al. Among authors: Matos AM. Microbiol Immunol. 2019 Oct 30. doi: 10.1111/1348-0421.12753. Online ahead of print. Microbiol Immunol. 2019. PMID: 31663631 Review.
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators.
Conniot J, Scomparin A, Peres C, Yeini E, Pozzi S, Matos AI, Kleiner R, Moura LIF, Zupančič E, Viana AS, Doron H, Gois PMP, Erez N, Jung S, Satchi-Fainaro R, Florindo HF. Conniot J, et al. Among authors: Matos AI. Nat Nanotechnol. 2019 Sep;14(9):891-901. doi: 10.1038/s41565-019-0512-0. Epub 2019 Aug 5. Nat Nanotechnol. 2019. PMID: 31384037
Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.
Matos AI, Carreira B, Peres C, Moura LIF, Conniot J, Fourniols T, Scomparin A, Martínez-Barriocanal Á, Arango D, Conde JP, Préat V, Satchi-Fainaro R, Florindo HF. Matos AI, et al. J Control Release. 2019 Aug 10;307:108-138. doi: 10.1016/j.jconrel.2019.06.017. Epub 2019 Jun 19. J Control Release. 2019. PMID: 31226355 Review.
Network Biology Identifies Novel Regulators of CFTR Trafficking and Membrane Stability.
Loureiro CA, Santos JD, Matos AM, Jordan P, Matos P, Farinha CM, Pinto FR. Loureiro CA, et al. Among authors: Matos AM, Matos P. Front Pharmacol. 2019 Jun 4;10:619. doi: 10.3389/fphar.2019.00619. eCollection 2019. Front Pharmacol. 2019. PMID: 31231217 Free PMC article.
Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas.
Aaberg-Jessen C, Sørensen MD, Matos ALSA, Moreira JM, Brünner N, Knudsen A, Kristensen BW. Aaberg-Jessen C, et al. Among authors: Matos ALSA. BMC Cancer. 2018 Mar 9;18(1):270. doi: 10.1186/s12885-018-4179-y. BMC Cancer. 2018. PMID: 29523123 Free PMC article.
Metallopeptidase inhibitor 1 (TIMP-1) promotes receptor tyrosine kinase c-Kit signaling in colorectal cancer.
Nordgaard C, Doll S, Matos ALSA, Høeberg M, Kazi JU, Friis S, Stenvang J, Rönnstrand L, Mann M, Manuel Afonso Moreira J. Nordgaard C, et al. Among authors: Matos ALSA. Mol Oncol. 2019 Dec;13(12):2646-2662. doi: 10.1002/1878-0261.12575. Epub 2019 Oct 24. Mol Oncol. 2019. PMID: 31545548 Free PMC article.
α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma.
Sainz V, Moura LIF, Peres C, Matos AI, Viana AS, Wagner AM, Vela Ramirez JE, S Barata T, Gaspar M, Brocchini S, Zloh M, Peppas NA, Satchi-Fainaro R, F Florindo H. Sainz V, et al. Among authors: Matos AI. Acta Biomater. 2018 Aug;76:193-207. doi: 10.1016/j.actbio.2018.06.029. Epub 2018 Jun 22. Acta Biomater. 2018. PMID: 29940370 Free PMC article.
162 results
Jump to page